Seeking Alpha

  AEterna Zentaris, Inc. - NASDAQ

11/27/2014, 8:21 AM ET
  • The Scientist | Send Message 9 Dec 2011

    If AEZS's perifosine had absolutely no effect or was detrimental to colon CA patients, the DSMB would have stopped the trial in August.
    Reply (1)
    • Funkengruven | Send Message 9 Dec 2011
      : ;-) That's what I'm thinking!
      AEZS vs. ETF Alternatives
      Company Description
      AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology.
      Sector: Healthcare
      Industry: Biotechnology
      Country: Canada